Migraine Tip of the Month: Want to avoid prevention therapy? Up your acute treatment game
/
In surveys of the general population, as many as 15 million American migraineurs report…
Read More
Latest News
Migraine Treatments of the Month: The Anti-CGRP Monoclonal Antibodies
/
Each of the mABs is effective in a high percentage of patients...
Read MoreMigraine Myth of the Month: Migraine always vanishes following menopause
/
Sounds good. And quite reasonable. After all, between the ages of 15 and 45 migraine is roughly 3 times…
Read MoreDoctor on Call
/
Madeline, a 28-year-old restaurant manager who lives in Manhattan Beach, California writes…
Read MoreLetter from the Editor
/
After 6 years this magazine’s most frequently downloaded article remains “Migraine 101” from the Fall 2017 issue…
Read MoreOptimal Pharmacologic Treatment of Acute Migraine Headache: Matching medication to headache intensity
/
As most migraineurs know well from personal experience, not all migraine episodes are created equal…
Read MoreMigraine Tip of the Month: Pregnant and migraine out of control? Consider Botox
/
OnabotulinumtoxinA (BotoxA) has been with us for over 30 years, was FDA-approved for the treatment of…
Read MoreMigraine Myth of the Month: Elimination of migraine triggers is highly effective in reducing migraine burden
/
Well, yes…but also no. Often helpful, definitely. But “highly effective”, not so much…
Read MoreMigraine Treatments of the Month: A root, a spray and an intravenous infusion: 3 different approaches to migraine relief
/
Butterbur (scientific name Petasites hybridus) is a member of the sunflower family that grows in marshes and is largely found in southern Europe and parts of Asia…
Read MoreShout-Out: M&N’s Pizza - Bethesda, MD
/
Every so often you happen upon that book, artwork, shop, restaurant, hotel or museum that strikes a particular chord…
Read MoreLetter from the Editor
/
Just slightly less than 30 years ago, in December 1992, injectable sumatriptan (Imitrex) was approved by the FDA for the treatment of acute migraine headache…
Read MoreFor those who prefer to read the Summer 2022 issue's feature article in Portuguese...
/
Na prática médica e especificamente na prática cefaliátrica, as seguradoras geralmente requerem autorizações prévias (AP) antes de reembolsar ou pagar o paciente ou o provedor de serviços como a clínica de exames ou de tratamento como no botox…
Read MoreDancing With the Devil: A Physician’s Perspective
/
In the practice of medicine generally and headache medicine specifically, insurers often require “prior authorization” (PA) before they will reimburse…
Read MoreMono-therapy vs Polytherapy: When is Two Better Than One?
/
In the last issue of this magazine we focused on the relative attractiveness of the “old” medications for migraine treatment compared to the newer “designer drugs”…
Read MoreWhat’s New? Developments from the front lines of migraine research
/
Atogepant (Qulipta): an attractive new option for suppressing chronic migraine
Migraine “Rescue”: don’t like self-injection? how about a nasal spray?
Alzheimer’s, Dementia and Migraine: where things presently stand
Migraine and Sex: an update and a stimulating(!) new avenue of research
Lagniappe: A Gift: The Chesapeake and Ohio (C&O) Canal
/
The Chesapeake and Ohio (C&O) Canal was conceived by George Washington, the ever-entrepreneurial Father of Our Country, as a means of…
Read MoreMigraine Treatment of the Month: Divalproex sodium: an oldie... but a goodie?
/
In 1978 valproic acid (also known as sodium valproate or divalproex sodium) was approved by the FDA for seizure prevention…
Read MoreMigraine Myth of the Month: The triptans are potentially dangerous drugs
/
The first “designer drug” for migraine treatment, injectable sumatriptan (Imitrex), was approved by the FDA for general clinical use in this country in 1992…
Read MoreDoctor on Call: What the heck is “transformed migraine”?
/
Sandra, a 37-year-old computer software engineer and mother of three from Colorado Springs, writes:
Read More
